Click here to read the latest top cannabis stocks year-to-date list.

Amid a global pandemic, the cannabis stock market has taken heavy losses as the industry adjusts to developing metrics and the evolution of consumer trends.

As the US election draws nearer, expectations are rising for what’s in store in the remaining months of 2020. For now, the Investing News Network is looking back at the performance of stocks in the at-large cannabis universe over the first three quarters of the year.

Overall, the cannabis space has taken some serious lumps since 2019 following poor performances by leading companies, particularly in the Canadian market.

In 2020, experts agree the wedge is growing between companies that are performing well and those that are lagging behind. Whereas before cannabis investments encompassed a large collection of public names, investors are now placing wiser and more specific bets.

Data for this article was collected on October 9, 2020, and the companies included had to meet a minimum market cap requirement of C$10 million. Top cannabis stocks year-to-date on the NYSE, NASDAQ, TSX, TSXV and CSE were considered.

1. Vibe Growth (CSE:VIBE,OTC Pink:VBSCF)

Year-to-date gain: 477.78 percent; current market cap: C$41.76 million; current share price C$0.52

Vibe Growth is a cannabis company based in the expansive California state market. This retailer and operator offers consumers its extensive line of products at the three stores it manages in the state.

This past quarter, the company added to its portfolio in California, and agreed to acquire a Ventura Cannabis and Wellness (CSE:VCAN,OTC Pink:CVHIF) cannabis retailer subsidiary in Portland, Oregon.

As part of its positive performance, the company reported a profitable operating period for the three months ended on June 30. “Not only did we achieve record dispensary sales and increased cultivation yields, but Vibe also achieved record EBITDA and after-tax net income,” said CEO Mark Waldron.

2. IM Cannabis (CSE:IMCC)

Year-to-date gain: 359.46 percent; current market cap: C$266.53 million; current share price C$1.70

This Israel-based cannabis operator offers medical products in the country and holds a subsidiary in Germany to distribute its offerings in the European market.

This past quarter, the company solidified its presence in Germany by beginning the sale of its IMC-branded cannabis products.

As part of its operating quarter ended on June 30, the company reported a significant uptick in revenue. However, the firm still saw a net loss of just under C$10 million and an adjusted EBITDA loss of C$1 million, both greater than the same reporting period in 2019.

3. Next Green Wave Holdings (CSE:NGW,OTCQX:NXGWF)

Year-to-date gain: 180 percent; current market cap: C$46.59 million; current share price C$0.28

Next Green Wave Holdings is an established seed-to-sale operator in the modern California state market.

In a recent update, this operator celebrated positive metrics for adjusted EBITDA and cash flow for the three operating months of July, August and September.

In an update to shareholders, CEO Mike Jennings said the company has three goals ahead of itself: continue to operate and improve its production numbers; grow revenue of branded products and add novel items like extracts; and take its extraction operation online before the end of the year.


Year-to-date gain: 166.67 percent; current market cap: C$37.45 million; current share price C$0.32

Another of the top cannabis stocks year-to-date, CB2 Insights went public in early 2019, selling itself to investors as an ancillary cannabis opportunity based on the technology side of business. The company offers clinical management and data collection software.

In August, the company reached a milestone by reporting its first-ever EBITDA-positive operating quarter.

CB2 Insights closed a private placement worth C$3 million from a group of investors led by Merida Capital Partners and Affiliates, a well-known cannabis-related investment group. The deal closed in September, but not before being upsized to just over C$5 million.

5. XPhyto Therapeutics (CSE:XPHY,OTCQB:XPHYF)

Year-to-date gain: 149.02 percent; current market cap: C$139.42 million; current share price C$2.54

One of the growing trends in the cannabis investment proposition is the magnification of companies performing alongside traditional growth and sales operations. One such company doing well for itself in 2020 is XPhyto Therapeutics.

This company approaches cannabis by way of researching novel drug delivery technologies. XPhyto holds subsidiaries in the European market that are involved in trials for a CBD drug treating epilepsy.

This year, the company has received a boost in its performance thanks to the measures it has launched for COVID-19 testing. XPhyto told investors it is eyeing Q1 2021 as a potential timeline for regulatory approval of its rapid screening test.

Investor takeaway

While some of the biggest established names in the cannabis market have faced struggles, the industry has grown to the point where it holds many diversified opportunities.

This list of the top cannabis stocks year-to-date proves cannabis investment is no longer a blanket arena where one kind of business applies.

At the same time, experts have pointed to potential signals that a recovery is coming for some large and medium-size public names in the space.


Want more details? Check out these articles for more INNdepth coverage:

Want an overview of investing in cannabis stocks? Check out Investing in the Cannabis Industry

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or the “Company”), is pleased to announce a non-brokered private placement offering of up to 7,000,000 units (” Units “), at $0.20 per unit, for total gross proceeds of up to $1,400,000 .

Keep reading... Show less

 Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), announces that it has engaged C&CS Atlantic Inc. to complete  testing required to commercially launch PozGlass SCM. The principal of C&CS Atlantic is Dr. Michael Thomas .

Keep reading... Show less

 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) continues to expand in the Massachusetts market and is pleased to announce that it received approval from the Brookline, Massachusetts Planning Board to start the construction of a new Mission branded dispensary. The location will initially serve adult-use customers and is on track to open in Q2 2021.

4Front’s new dispensary will be located at 1024 Commonwealth Avenue in Brookline , with the storefront opening to Boston proper. The location will serve the Brookline , Allston corridor, a vibrant community within the wider Boston University and Boston metropolitan area. Mission Brookline will carry a full line of 4Front’s high-quality, adult-use cannabis brands and products, including flower, extracts, edibles, and vapes. Mission’s expertly trained staff will be available to ensure an informative, welcoming, and inclusive experience for all consumers. Adult-use customers will be able to browse live inventory, place online orders and pickup orders in-store.

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the closing of a sale leaseback transaction with Innovative Industrial Properties, Inc. (“IIP”) (NYSE:IIPR).

Keep reading... Show less